Mary Ann Liebert Inc.: Can Cannabinoids Help Treat Obsessive-Compulsive Disorder?
June 01, 2019
June 01, 2019
NEW ROCHELLE, New York, June 1 -- Mary Ann Liebert Inc. issued the following news release, dated May 30:
The body's endocannabinoid system, due to the critical role it plays in regulating neurotransmitter signaling, is an enticing target for drug development against disorders associated with anxiety, stress, and repetitive behaviors, such as obsessive-compulsive disorder (OCD). A comprehensive new review article that provides an overview of this complex system, endogenous and exogen . . .
The body's endocannabinoid system, due to the critical role it plays in regulating neurotransmitter signaling, is an enticing target for drug development against disorders associated with anxiety, stress, and repetitive behaviors, such as obsessive-compulsive disorder (OCD). A comprehensive new review article that provides an overview of this complex system, endogenous and exogen . . .